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An experimental genetically 
attenuated live vaccine to prevent 
transmission of Toxoplasma gondii 
by cats
Chandra Ramakrishnan1, simone Maier1, Robert A. Walker1, Hubert Rehrauer  2, 
Deborah e. Joekel1, Rahel R. Winiger1, Walter U. Basso1, Michael e. Grigg3, Adrian B. Hehl1, 
peter Deplazes1 & Nicholas C. smith  4,5
Almost any warm-blooded creature can be an intermediate host for Toxoplasma gondii. However, 
sexual reproduction of T. gondii occurs only in felids, wherein fertilisation of haploid macrogametes by 
haploid microgametes, results in diploid zygotes, around which a protective wall develops, forming 
unsporulated oocysts. Unsporulated oocysts are shed in the faeces of cats and meiosis gives rise to 
haploid sporozoites within the oocysts. these, now infectious, sporulated oocysts contaminate the 
environment as a source of infection for people and their livestock. RNA-seq analysis of cat enteric 
stages of T. gondii uncovered genes expressed uniquely in microgametes and macrogametes. A 
CRISPR/Cas9 strategy was used to create a T. gondii strain that exhibits defective fertilisation, 
decreased fecundity and generates oocysts that fail to produce sporozoites. Inoculation of cats with 
this engineered parasite strain totally prevented oocyst excretion following infection with wild-type T. 
gondii, demonstrating that this mutant is an attenuated, live, transmission-blocking vaccine.
Toxoplasma gondii is a zoonotic, apicomplexan parasite that belongs to the subclass Coccidia. On one hand, this 
protozoan is an important cause of abortion in sheep and, thereby, causes considerable economic losses1,2. On the 
other hand, the global prevalence of T. gondii infection in humans is estimated to be 30% and, in some regions, 
notably South America and Africa, the prevalence is much higher3. Although for most infected people the disease 
is asymptomatic, a first infection during pregnancy can lead to congenital toxoplasmosis, which may cause abor-
tion or have serious effects for the new-born – effects that may persist for life (for example, mental retardation, 
hearing and loss of vision). Clinical symptoms, particularly ocular toxoplasmosis, can also occur in otherwise 
healthy adults but serious disease and death is more often associated with immunosuppressed individuals. Even 
though a small percentage of people infected with T. gondii may be affected adversely, the sheer magnitude of the 
number of people infected for life by this most successful and insidious of parasites means that, nevertheless, large 
numbers of people suffer significant morbidity as a result of infection2–6.
Toxoplasma gondii has a complex life cycle. It is able to infect a wide range of warm-blooded intermediate 
hosts by virtue of a highly adaptable, asexual stage, the tachyzoite, which is capable of attaching, invading, mod-
ifying and replicating rapidly within a diversity of nucleated cells7,8. Intermediate hosts mount robust immune 
responses9,10 that drive tachyzoites to convert to bradyzoites, which are persistent, asexual and infectious forms 
of the parasite harboured in cysts within brain and muscle cells for life. Only felids serve as definitive hosts for 
T. gondii and, in them, T. gondii develops through a classical coccidian life cycle7,8 in the epithelia of the small 
intestine in addition to spreading systemically as in intermediate hosts. Thus, predation of an infected intermedi-
ate host by a naïve definitive host results in bradyzoite invasion of enterocytes, initiating several rounds of rapid 
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asexual reproduction, producing merozoites, followed by transformation into male (micro-) and female (macro-) 
gametes. Fertilisation of macrogametes by microgametes results in the production of zygotes, the only diploid 
stage in the life cycle. Resilient bi-layered walls form around the zygotes, creating oocysts. Oocysts are, initially, 
unsporulated and non-infectious but, given sufficient warmth, humidity and oxygen, will undergo meiosis and 
sporulate, ultimately producing two sets of four haploid sporozoites, contained within a second set of walled 
structures, called sporocysts7,8. These sporulated oocysts are infectious. It must be noted, however, that there is 
some contention about whether fertilisation is a necessary precursor to development of sporulated oocysts11.
At any one time, 1% of the world’s ~600 million domestic felids are shedding oocysts of T. gondii in their fae-
ces, and an individual cat may shed up to 55 million oocysts per day for an average of 8 days; moreover, oocysts 
of T. gondii can survive in the environment for many months, even years6. In addition, cats shedding oocysts in 
farming areas leads to infection of livestock and development of microscopic, infectious cysts in tissues. When 
all these facts are combined, it is obvious that human exposure to infectious stages of T. gondii, either via oocysts 
or tissue cysts, occurs frequently. Which route of infection is more important is still debated but it is clear that, 
either way, every human infection results directly or indirectly from cats shedding oocysts into the environment.
Oocysts are, thus, the nexus of the life cycle of T. gondii and, therefore, interventions that interfere with the 
production and/or sporulation of oocysts will ultimately reduce environmental contamination and, hence, the 
incidence of toxoplasmosis in humans and livestock. Although we understand, quite well, the dynamics of the 
cell biology of sexual reproduction and oocyst wall formation in T. gondii7,8 and related coccidians within the 
genus, Eimeria8,12, we know rather less about the molecular underpinnings of these events, notwithstanding 
recent breakthroughs in transcriptomic13 and proteomic14 analyses of T. gondii oocysts, which have identified 
some potentially key structural components. We recently used a comparative RNA-Seq approach to identify genes 
expressed specifically in the gametocytes of Eimeria tenella15, creating a dataset that embodies a snapshot of 
molecules and mechanisms associated with sexual reproduction and oocyst formation. Here, we take a similar 
approach for T. gondii to identify candidate targets for transmission-blocking control strategies. Using data min-
ing approaches, we have pinpointed genes coding for micro- and macrogamete-specific proteins with putatively 
important roles in fertilisation and oocyst wall formation. We used CRISPR/Cas9 to delete the gene for one puta-
tive fertilisation factor, HAP2, and thereby created a mutant of T. gondii that cannot form infectious sporozoites 
within oocysts. We demonstrated that this mutant parasite line can be used as a live, attenuated vaccine to totally 
prevent transmission of T. gondii by cats.
Results
transcriptome sequencing of feline enteric forms of Toxoplasma gondii. Samples were taken from 
the small intestinal epithelium of eight cats infected with T. gondii CZ clone H3 at 3, 5 and 7 days post-inoculation 
using our published protocol16. Hierarchical clustering of samples showed that time points do not necessarily 
reflect the progress of development (Figure S1a). We therefore used the clustering as a basis to order the samples 
of the enteroepithelilal stages and validated this by heat maps of genes being significantly differentially expressed 
(Figure S1b). Thus, samples were classified into five enteroepithelial stages (EES) of development, designated as 
follows: EES1 = very early (isolated from one cat); EES2 = early (isolated from two cats); EES3 = mixed (isolated 
from two cats); EES4 = late (isolated from two cats); EES5 = very late (isolated from one cat). Two samples of 
tachyzoites from independent human foreskin fibroblast (HFF) cultures were also included in analyses. Paired-
end Illumina RNA-Seq reads were mapped to all 8,322 open reading frames (ORFs), representing unique proteins 
annotated in the T. gondii genome (www.toxodb.org) (Tables S1–S3). The variability of reads mapped to T. gondii 
sequences in the cat stage samples is due to the asynchronous nature of coccidian development as well as to the 
variability in magnitude of infection (Table S1). The highest parasite to host read ratio was achieved in late to very 
late enteroepithelial stages as well as in tachyzoite samples. Comparative analysis of normalised (log2) read ratios 
between stages is depicted as heat maps (Fig. 1a–f) and scatter plots (Figure S2). The greatest stage-specific differ-
ences in mRNA levels was found between the tachyzoite and all EES samples, and between EES5 and all other EES 
samples. In comparison, the differences between EES1, EES2, EES3 and EES4 were relatively minor, indicating 
that the EES5 samples provide a useful resource for identification of genes that are differentially regulated during 
gametogenesis (Fig. 1g).
Oocyst and oocyst wall-specific genes. A transmission-blocking vaccine against poultry eimeriosis has 
been developed; it targets the gametocyte proteins GAM56 and GAM82, which are produced in macrogametes 
and stored within the wall forming bodies prior to incorporation into the oocyst wall12. This highlights the attrac-
tiveness of oocyst wall and/or surface proteins as transmission-blocking targets. Although microarray data of 
sporulated and unsporulated T. gondii oocysts13 as well as proteomic data of oocyst versus sporocysts/sporozoite 
fractions14 are available, expression datasets for the enteroepithelial stages in the definitive cat host remain under-
studied. Using criteria of >4-fold increase of expression from EES5 to EES1, low expression in tachyzoites, and 
peak expression in EES5, we have compared mRNA levels of ORFs encoding oocyst wall proteins (OWPs) in T. 
gondii (Table S4) and found that read numbers mapping to owp1, 6, 9, hypothetical owp1 (howp1) and two, as yet 
uncharacterised, owp orthologs (TGME49_268225 and TGME49_268230) increase from EES1 to EES5, presum-
ably as the life cycle of the parasite progresses (Fig. 2a), supporting the idea that these are indeed genes that code 
for oocyst wall proteins in T. gondii. In further support of this conclusion, OWP6 has been detected previously in 
the oocyst wall of T. gondii14 and a homologue of owp6 has also been found in the gametocyte transcriptome of E. 
tenella, with the corresponding protein detected in the wall forming bodies of macrogametocytes15.
Toxoplasma gondii oocyst and sporocyst walls display autofluorescence if illuminated by 405 nm laser light. 
This is thought to be due to the dityrosine bonds formed between tyrosine-rich proteins (TRP) in the oocyst and 
sporocyst wall, a model that was first proposed for Eimeria17. Accordingly, ORFs coding for T. gondii TRP were 
prominent in the data set of genes meeting our criteria for upregulated expression in EES5 (Fig. 2b). Additionally, 
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Figure 1. Identification of developmentally regulated transcripts as enteric development of Toxoplasma gondii 
progresses in the cat. The RNA-Seq librairies of tachyzoites (T) and different enteroepithelial stages (EES) in the T. 
gondii life cycle were subjected to pair-wise heirarchical clustering (EES1 = very early enteroepithelial stages isolated 
from one cat; EES2 = early enteroepithelial stages isolated from two cats; EES3 = mixed enteroepithelial stages 
isolated from two cats; EES4 = late enteroepithelial stages isolated from two cats; EES5 = very late enteroepithelial 
stages isolated from one cat; T = tachyzoites from two independent human foreskin fibroblast culture samples). Heat-
mapping of Pearson’s correlation coefficient reveals similarities and differences in transcriptome development for (a) 
EES2 vs EES1, (b) EES3 vs EES2, (c) EES4 vs EES3, (d) EES5 vs EES4, (e) EES5 vs EES1 and (f) EES1 vs tachyzoites. 
Heatmaps show the log2 values of the ratio of reads between two stages. Only genes with significant differential 
expression (DE) are plotted; the significance threshold is set to 0.01 and the required minimum log2 ratio is 0.5. 
Coloured bars (blue, cyan, green, orange, red and yellow) on the left mark gene clusters. (g) Stacked bar charts show 
the number of differentially expressed genes with different levels of regulation in various comparisons of the EES as 
well as EES1 versus tachyzoites. Comparisons are performed using averages where applicable.
www.nature.com/scientificreports/
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expression of genes coding for enzymes proposed to be involved in the catalysis of dityrosine bond formation 
in the oocyst wall – AO2, an oxidoreductase and several subtilisins – was also upregulated (Fig. 2c; Table S4). 
Similarly, stage-specific increase in mRNA levels was observed for ORFs coding for, fasiclin and PAN/Apple 
domain containing proteins (Fig. 2b) as well as for the metabolic enzyme, alanine dehydrogenase, and several 
hypothetical proteins (Fig. 2d). These proteins/genes were identified previously in the oocyst wall proteome14 
and/or transcriptome13.
Identification of microgamete-specific genes. Our previous study15 identified putative 
microgamete-specific ORFs coding for factors involved in axoneme and flagella assembly and construction, DNA 
Figure 2. Inceased levels of transcripts coding for oocyst wall proteins, surface proteins and enzymes 
potentially involved in oocyst wall biogenesis. (a) Expression of genes coding for oocyst wall proteins (OWP) 
and a hypothethical OWP (HOWP1). (b) Genes encoding tyrosine-rich proteins (TRP), fasciclin (Fas) 
and PAN/Apple (PAN) domain-containing proteins. (c) Genes encoding enzymes involved in oocyst wall 
formation such as amine oxidase 2 (AO2) and subtilisins (SUB), putatively responsible for cross-linking 
tyrosines. (d) Other genes that encode proteins that have been detected in the oocyst wall14. GPI trans., GPI 
transamidase (subunit PIG); Fatty a sy., type I fatty acid synthase; Oxidored., oxidoreductase; Ala dehyd., 
alanine dehydrogenase; NF7, nuclear factor 7; Hypo., hypothetical protein. (FPKM = Fragments per kilobase 
of transcript per million mapped reads, using averages where applicable, for: EES1 = very early enteroepithelial 
stages isolated from one cat; EES2 = early enteroepithelial stages isolated from two cats; EES3 = mixed 
enteroepithelial stages isolated from two cats; EES4 = late enteroepithelial stages isolated from two cats; 
EES5 = very late enteroepithelial stages isolated from one cat; T = tachyzoites from two independent human 
foreskin fibroblast cultures).
www.nature.com/scientificreports/
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condensation, and gamete fusion in E. tenella. We therefore conducted data mining of the T. gondii RNA-Seq data 
using the following criteria to identify candidate microgamete-specific ORFs: >4-fold up from EES5 to EES1; low 
expression in tachyzoites; peak expression in EES5; annotations from ToxoDB and Blast2GO (the more compre-
hensive being used for descriptions) and GO terms for selection (motile cilium etc). Our findings are presented 
in Fig. 3 and Table S5. In general, we observed low FPKMs compared to other stages, which we also saw in E. 
tenella microgamete genes15. Also in keeping with our observations for E. tenella, we detected upregulation in the 
expression of genes coding for tubulins, dyneins, radial spokes, basal body family proteins (TGME49_283765 
and TGME49_260000), a centrin family protein (TGME49_237490), kinesins, and genes coding for intraflagellar 
transport proteins. Upregulation of expression of the gene for SAS-6, a basal body protein known to be specific to 
male gametocytes in Plasmodium18 and important for fertilisation, was not detected in T. gondii EES but we did 
note upregulation of TGME49_297820, a gene coding for an armadillo-repeat containing protein annotated as 
sperm associated antigen 6 (Fig. 3a). An orthologue is abundant in the E. tenella gametocyte transcriptome15 and 
the Plasmodium falciparum orthologue, PF16, is part of the central apparatus of the axoneme and essential for fla-
gellar motility and fertilisation19. This protein is also important for flagellar motility in Trypanosoma brucei20 and 
Giardia lamblia21, as well as mice22. Other sperm-associated genes detected included: TGME49_289260, sperm 
associated antigen 17: central apparatus, critical for motile cilia in mice23, TGME49_278710, primary ciliary dys-
kinesia protein 1; TGME49_207790, an enkurin thought to be involved in signal transduction in sperm24, which 
was also detected in E. tenella15, TGME49_293850, clusterin-associated protein 1, a key regulator of hedgehog 
signalling, intraflagellar transport B complex protein in mice;25 and TGME49_243550, SHIPPO-1, localised to 
sperm tail26. Finally, expression of hap2 (TGME49_285940) was observed to increase as enteric development of 
T. gondii in the intestine of the cat proceeded (Fig. 3c, Table S5, Fig. 4a), in accord with our findings for E. tenella, 
which additionally documented specific localisation of HAP2 in microgametocytes15. We selected hap2 for dele-
tion from the T. gondii genome (Fig. 4b) to test the proof of principle that a deficiency in a key microgamete 
protein would (a) affect oocyst development and (b) result in a line of T. gondii that could be used to immunise 
cats to prevent oocyst shedding.
oocysts from a Toxoplasma gondii hap2 knockout fail to sporulate. We used a CRISPR/Cas9 
strategy to disrupt the hap2 ORF in the genome of T. gondii CZ clone H3 to create a HAP2 knockout parasite 
Figure 3. Increased levels of transcripts coding for putative microgamete proteins. (a) Expression of genes 
coding for axonemal proteins. Tub., tubulin; DYNLC, dynein light chain; Ax., axonemal; DLP, dynein light 
polypeptide; Tctex-1, family of dynein light chains; DYNIC, dynein intermediate chain; DYNHC, dynein heavy 
chain; reg., region; DNAH2, axonemal dynein heavy chain 2 family protein; ODA, outer dynein arm docking 
complex protein; DRC, dynein regulatory complex; RSP, radial spoke protein; BB, basal body protein; SPAG, 
sperm-associated antigen; ARMC, armadillo/beta-catenin family repeat-containing protein; B9D, B9 domain-
containing protein. (b) Gene expression of flagellar transport proteins. IFT, interflagellar transport protein; 
KIN, kinesin; KINHC, kinesin heavy chain; KCBP, calmodulin-binding carboxy-terminal kinesin-like family 
protein; ass., associated. (c) Other microgamete genes. HAP, hapless gene; Flag assoc., flagellar-associated; 
Flag rel., flagellar-related; PACRG, Parkin co-regulated gene protein; MNS, meiosis-specific nuclear structural 
protein; PCD, primary ciliary dyskinesia protein; H-SHIPPO, human sperm tail protein; CLUAP, clusterin-
associated protein; CCDC, coiled-coil protein; REJ, receptor for egg jelly; WD G-beta, tryptophan-aspartic 
acid G-beta repeat-containing protein; EF hand, EF hand family protein; Gas8, growth arrest-specific protein; 
PF2, PF2 arrest specific protein; TRR, tetratricopeptide repeat-containing protein; Mitostat., tumor suppressor 
mitostatin; LRR, leucine rich repeat-containing protein; Hypo., hypothetical protein. (FPKM = Fragments 
per kilobase of transcript per million mapped reads, using averages where applicable, for: EES1 = very early 
enteroepithelial stages isolated from one cat; EES2 = early enteroepithelial stages isolated from two cats; 
EES3 = mixed enteroepithelial stages isolated from two cats; EES4 = late enteroepithelial stages isolated from 
two cats; EES5 = very late enteroepithelial stages isolated from one cat; T = tachyzoites from two independent 
human foreskin fibroblast cultures).
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(HAP2 KO) line (Fig. 4b) and examined it for off-target lesions by sequencing its genome and comparing it to 
CZ clone H3; in addition to the expected insertion of a “GG” mutation at the designated target site (after nt 18 
of the first exon) resulting in a frameshift (Fig. 4b), we detected a second mutation in the T. gondii genome but 
only in an intron of TGME49_223060. Our transcriptome data indicates that TGME49_223060 is expressed 
consistently across all stages of T. gondii (Table S2, Figure S3a). The mutation is a deletion of “TT” at the 3’ end 
of intron 4 of TGME49_223060, situated upstream of a potential splicing branch point in, or upstream of, the 
polypyrimidine tract (Figure S3b). Experimental validation of splicing was not possible since the first five exons 
of TGME49_223060 are not expressed in tachyzoites. Thus, we cannot completely rule out the possibility that 
splicing is unaffected by the mutation but the phenotype observed in the HAP2 KO is wholly consistent with an 
anticipated defect in fertilisation potential (see below).
Tachyzoites of HAP2 KO T. gondii were cultured in human foreskin fibroblasts (HFFs) and used to infect 
mice. Brains, hearts, lungs, eyes and muscles from these mice were used to prepare infectious inocula for cats and 
oocysts collected from the faeces of infected cats 5–9 days later. It was only possible to recover relatively small 
numbers of oocysts of T. gondii HAP2 KO and no sporulation of these oocysts occurred in response to exposure 
to 2% H2SO4 (Table 1). Furthermore, oocysts of HAP2 KO parasites were mis-shapen though autofluorescence at 
405 nm illumination was preserved (Fig. 4c), indicating formation of dityrosine bonds in the oocyst walls.
To assess fertilisation status and ploidy of the HAP2 KO oocysts, we performed quantitative real-time PCR 
on DNA extracted from T. gondii CZ clone H3 and HAP2 KO oocysts. Upon fertilisation, the nuclear genome is 
doubled and meiosis occurs within the first few hours after fertilisation, even before sporoblast formation, to form 
four nuclei27. We amplified actin as a nuclear gene and compared its amplification by PCR with that of chaperone 
clp, which is encoded on an apicoplast genome fragment. The male gamete lacks an apicoplast and, therefore, 
Figure 4. Oocysts of HAP2-deficient Toxoplasma gondii (HAP2 KO) exhibit aberrant morphology. (a) 
Expression of hap2 is upregulated as development of T. gondii progresses in the cat intestine (T = tachyzoites, 
EES = enteroepithelial stages, FPKM = fragments per kilobase of transcript per million mapped reads). 
(b) A CRISPR/Cas9 strategy was used to delete hap2 from the genome of T. gondii CZ clone H3. The 
mutant locus contains an insertion of “GG” which is shown as an alignment and in the chromatogram. (c) 
Representative oocysts and oocyst-like structures observed in CZ clone H3 and HAP2 KO parasites exploiting 
the autofluorescence of the oocyst/sporocyst wall under the DAPI channel and using differential interference 
contrast settings, demonstrating that oocysts of HAP2-deficient parasites are mis-shapen but autofluorescence 
is preserved, indicating formation of dityrosine bonds in the oocyst walls. Bar = 5 µm.
www.nature.com/scientificreports/
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oocysts contain only the maternally inherited apicoplast28 with a multicopy genome29,30 allowing the use of an 
apicoplast gene as a reference point. Exploiting the relative comparison method31, we estimated that the nuclear 
genome of CZ clone H3 is, as expected, 4-fold larger (range of 3.6–4.2-fold, over three experiments; Table 2) than 
that of HAP2 KO indicating that no fertilisation has occurred in the HAP2 KO parasites.
prior infection of cats with hap2 knockout bradyzoites prevents oocyst excretion after chal-
lenge infection with wild-type parasites. Fourteen cats were allocated into three groups of five, four 
and five, respectively: one group was inoculated twice, 5 weeks apart, with T. gondii CZ clone H3 bradyzoites; a 
second group was inoculated in the same manner with T. gondii HAP 2 KO bradyzoites; and a third group was 
left uninoculated (i.e., naïve). All three groups were ultimately challenged with CZ clone H3 bradyzoites, 5 weeks 
after the second inoculation (Fig. 5a). Blood samples were taken from all cats before the first inoculation and at 
4–5 week intervals thereafter. Anti-Toxoplasma antibodies in these blood samples were assessed by ELISA and 
confirmed that, first, all cats were Toxoplasma-naïve prior to their first inoculation and, second, that all cats devel-
oped similar levels of anti-Toxoplasma antibodies following their first inoculation (Fig. 5b).
Oocyst shedding by inoculated and naïve cats was checked throughout the time-course of the challenge 
trial (Table 3). In the days following the initial inoculation, no oocysts were detected in the group of naïve 
cats. Oocysts were detected in the cats inoculated with HAP2 KO bradyzoites but only at levels below the 
level of reliable enumeration (ie, less than 1,600 oocysts in a 2day sample of faeces); moreover, these oocysts 
were mis-shapen, as reported above (Fig. 4c). Following the initial inoculation with CZ clone H3 bradyzoites, 
oocysts were first detected in faeces of cats on days 3–4 post-inoculation and oocyst shedding ceased by day 
13 post-inoculation for one cat and before day 15 post-inoculation for the other four cats in this group. Peak 
oocyst shedding occurred on days 5–6 for all cats. Total oocyst shedding varied from 1–36 million per cat 
(Table 3). Such variability is not unusual amongst cats infected with T. gondii, even under strictly controlled 
conditions32–34. No oocyst shedding was observed for any cat in the days following the second inoculation. 
Following the final challenge inoculation with CZ clone H3 bradyzoites, none of the cats inoculated previously 
with either CZ clone H3 or HAP2 KO bradyzoites shed any oocysts (Table 3). However, the cats in the previously 
uninoculated group began shedding oocysts by day 4 (one cat) or day 5 (four cats) and continued to shed oocysts 
until day 11 (one cat), day 13 (three cats) or day 15 (one cat). Peak oocyst shedding occurred on days 5–6 for 
two cats and on days 7–8 for the other three cats in this group. Total oocyst output over the patent period varied 
from 2–149 million per cat (Table 3) demonstrating, in combination with antibody (Fig. 5b) responses, that the 
challenge infection was robust.
In order to test if inoculation with HAP2 KO parasites also prevented systemic infection, brains from three cats 
inoculated with HAP2 KO tissue cysts and challenged with T. gondii CZ clone H3 were harvested and homoge-
nised. These brain homogenates were enriched for tissue cysts by Percoll gradient fractionation and used to infect 
HFF in vitro cultures. Fractions from all three cats established infection in tissue culture and the tachyzoites were 
shown to be CZ clone H3 by PCR and subsequent diagnostic digestion of the PCR products (Fig. 5c; full gel pre-
sented as Figure S5); thus, whilst PCR products from tachyzoites derived from cat tissue cysts that should be a size 
of 475 bp could be digested with XcmI to 353 bp and 120 bp, PCR products from HAP2 KO tachyzoites gave rise 
to a product of 0.5 kb that could not be digested. Analysis of the nucleotide sequence of the PCR product (data not 
shown) confirmed the CZ clone H3 phenotype of the tachyzoites. This indicates that although prior inoculation 
with HAP2 KO parasites totally prevents subsequent oocyst shedding, systemic infection can still be established 
by the wild-type parasites used in the challenge infection.
Days post exposure to 
2% H2SO4
Percentage of CZ clone H3 
oocysts sporulated
Percentage of HAP2 KO 
oocysts sporulated
0 0, 0, 0, 0 (0 ± 0) 0
2 46, 45, 46, 43 (45 ± 1) 0
4 69, 67, 71, 70 (69 ± 1) 0
8 79, 80, 79, 88 (82 ± 2) 0
Table 1. Exposure to 2% H2SO4 fails to induce sporulation of HAP2-deficient Toxoplasma gondii (HAP2 KO) 
oocysts.
Experiment
ΔCtactin-clp CZ 
clone H3
ΔCtactin-clp HAP2 
KO
ΔΔCt CZ clone 
H3-HAP2 KO
n-fold change CZ clone 
H3:HAP KO
1 5.573 ± 0.207 7.519 ± 0.263 −1.946 ± 0.335 3.9
2 4.845 ± 0.544 6.909 ± 1.327 −2.064 ± 1.434 4.2
3 5.595 ± 0.502 7.451 ± 0.124 −1.856 ± 0.517 3.6
Table 2. HAP2-deficient Toxoplasma gondii (HAP2 KO) oocysts do not undergo meiosis. Quantitative real-
time PCR results demonstrating the differences of Ct between actin and clp (ΔCt) ± standard deviation (SD), 
ΔΔCt ± SD between the CZ clone H3 and the HAP2 KO as well as an estimate of the n-fold change in the 
nuclear genome between the CZ clone H3 and the HAP2 KO.
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Discussion
In this study, we have used a comparative RNA-Seq transcriptomics approach to identify hundreds of genes 
putatively expressed specifically in the micro- and macrogametocytes of T. gondii (Figs 1–3, Tables S2–S5). This 
extensive data set provides a snapshot of the molecules that are potentially most important for the completion of 
the sexual phase of development of T. gondii and the formation of its oocysts, which are critical for transmission 
of this parasite from its definitive feline host to innumerable potential intermediate hosts. In combination with 
recently completed transcriptomes of E. tenella15 and Cryptosporidium parvum35, this transcriptome of the feline 
enteric stages of T. gondii provides a powerful comparative data set to facilitate identification of genes and pro-
teins that have important and conserved functions in sexual stage biology of the Coccidia – these are all possible 
targets for novel, transmission-blocking control strategies, including subunit vaccination. The ability of inocu-
lation of cats with a chemically-induced mutant of T. gondii (designated T-26336) to prevent oocyst excretion 
Figure 5. Inoculation of cats with HAP2-deficient Toxoplasma gondii (HAP2 KO) tissue cysts induces antibody 
responses but does not prevent systemic infection with wild-type T. gondii CZ clone H3 following oral challenge 
with tissue cysts. (a) Inoculation and challenge infection trial design showing age of cats, time of blood 
sampling of cats (red droplets), and timing of inoculations and challenge infections (arrows) on the x-axis. (b) 
ELISA results reveal formation of antibodies to T. gondii, following initial infection, by every cat. (c) Inoculation 
with HAP2 KO parasites does not prevent systemic (ie, tissue cyst) infection with CZ clone H3 parasites (PCR of 
cat brains reveals presence of CZ clone H3 DNA in cats inoculated with HAP2 KO parasites after challenge with 
CZ clone H3; the full length version of this image is presented as Supplementary Figure S5).
Group
Total oocyst counts (×106) Total oocyst counts (×106) Total oocyst counts (×106)
1st Inoculation 2nd Inoculation Challenge Infection
Inoculated with CZ clone H3 1, 4, 36, 7, 8 (11 ± 6) 0, 0, 0, 0, 0 (0 ± 0) 0, 0, 0, 0, 0 (0 ± 0)
Inoculated with HAP2 KO + 0, 0, 0, 0 (0 ± 0) 0, 0, 0, 0 (0 ± 0)
Naïve — — 25, 36, 2, 44, 149 (51 ± 25)
Table 3. Inoculation of cats with HAP2-deficient Toxoplasma gondii (HAP2 KO) tissue cysts prevents oocyst 
shedding on subsequent challenge with wild-type T. gondii CZ clone H3 tissue cysts.
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on subsequent challenge infection37 speaks to the validity of this proposal since this mutant develops normally 
through to micro- and macrogametocytes but fails to produce oocysts38, however, it must be acknowledged that, 
being a chemically-induced mutant line, T-263 likely harbours multiple mutations that are, as yet, undefined, 
apart from some enzymatic deficiencies39,40.
Prominent amongst the genes whose expression is upregulated in the sexual stages of T. gondii are those cod-
ing for proteins already highlighted as playing critical roles in coccidian sexual biology including tyrosine-rich 
and cysteine-rich oocyst wall proteins, and subtilisins and oxidoreductases thought to be involved in catalysing 
dityrosine cross-linking, leading to oocyst wall formation. It is now apparent that, in Toxoplasma, Eimeria and 
Cryptosporidium, the genes for oocyst wall proteins are expressed in macrogametocytes and the proteins stock-
piled rather than generated de novo in zygotes. As we noted for E. tenella15, many additional stage-regulated genes, 
including many hypothetical genes, are also identified in T. gondii by RNA-Seq; further comparative and func-
tional characterisation of these will allow fine dissection of coccidian sexual stage processes, including microg-
amete motility and fertilisation, in addition to oocyst wall biogenesis.
Amongst numerous putative microgamete-specific transcripts in our data, the one coding for a 
microgamete-specific gamete fusion protein, HAP2, particularly drew our attention because of its relatively 
well-defined localisation in microgametes, its role in membrane fusion leading to fertilisation and zygote forma-
tion in Plasmodium41,42 and Babesia43,44, and its prominence in the microgamete transcriptome of E. tenella15, all 
of which underscores its vital, conserved function in sexual reproduction in the Apicomplexa45. We engineered 
a HAP2 KO mutant of T. gondii, using a CRISPR/Cas9 strategy. We sequenced the genome of our HAP2 KO 
clone of T. gondii to not only confirm the disruption of hap2 expression but also to check for off-target mutations 
potentially introduced by our CRISPR/Cas9 approach. We thus identified a second mutation in our HAP2 KO 
line. Whilst we cannot be definitively sure that this second mutation does not affect the phenotype of our HAP2 
KO mutant, we believe this is unlikely because the mutation is in an intron of a hypothetical, MORN-repeat con-
taining gene that is expressed, apart from exons 1–5, consistently across all stages of development of T. gondii, and 
not specifically in late enteroepithelial stages of development. In any case, this mutant parasite proved eminently 
suitable for answering questions about the link between fertilisation and oocyst formation.
Inoculation of cats with bradyzoites of HAP2 KO parasites induced robust antibody responses, indicating the 
success of the infection (Fig. 5b); however, only mis-shapen oocysts could be recovered from the faeces of the 
infected cats (Fig. 4c). These oocysts failed to sporulate in response to exposure to H2SO4 (Table 1), indicating 
that fertilisation had not occurred. Additionally, oocysts of the HAP2 KO line showed no evidence of diploidy and 
consequent meiosis (Table 2), providing further evidence that fertilisation did not occur in the HAP2 KO para-
sites. Taken together, these results indicate that fertilisation is crucial for the formation of viable, diploid zygotes, 
destined to develop into infectious, sporulated oocysts. This argues against the idea that the development of spor-
ulated oocysts can occur without fertilisation11 but is in keeping with observations made in Eimeria indicating 
that fertilisation of macrogametes by microgametes is necessary for the production of viable, infectious oocysts 
since: (i) monoclonal antibodies to E. tenella microgametes can reduce oocyst formation46, and, (ii) reduced 
microgamete numbers lead to lower sporulation rates of oocysts47.
Our finding that our HAP2 KO parasites fail to complete fertilisation and undergo meiosis, and produce 
only small numbers of aberrant oocysts, establishes this mutant as a genetically-engineered, attenuated line of T. 
gondii, with a clear-cut phenotype. More importantly, the ability of inoculation of cats with HAP2 KO to totally 
prevent oocyst shedding by wild-type T. gondii (Table 3), establishes the proof-of-principle that interfering with 
fertilisation can completely block transmission of this parasite, a principle that can now be used to underpin the 
development of a transmission-blocking vaccine against T. gondii.
Materials and Methods
parasites. The type II strain CZ was originally isolated from the faeces of a Siberian tiger at the Dvůr Králové 
Zoo (Czech Republic) in 2005 by Dr. B. Koudela and, subsequently, cloned by limiting dilution to yield clone 
H3, which has been maintained by passages between HFF, sheep and/or mice, at the University of Zurich ever 
since. Tachyzoites were grown in confluent HFF monolayers cultivated in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Sigma-Adlrich) with high glucose supplemented with 10% heat inactivated foetal calf serum (FCS), 
additional 2 mM L-glutamine, 100 units/ml penicillin, 100 µg/ml streptomycin and 250 ng/ml amphotericin B. 
Tissue cysts for cat inoculations were obtained from brains of sheep or organs and muscles from mice and EES 
(sampled at day 3, 5 and 7) were harvested as described previously16.
cDNA library construction and RNA-seq. Samples of tachyzoites and EES of T. gondii for cDNA library 
preparation and RNA-Seq analysis were prepared as described previously16. RNA quality was assessed using the 
Agilent RNA 6000 Pico or Nano Kits (Agilent) and a Bioanalyzer 2100 (Agilent). RNA concentration was meas-
ured using a Qubit fluorometer (Invitrogen) together with the RNA assay (Invitrogen).
The TruSeq RNA Sample Prep Kit v2 (Illumina Inc.) was used in the succeeding steps. Briefly, total RNA sam-
ples (100–1000 ng) were poly-A enriched and then reverse-transcribed into double-stranded cDNA. The cDNA 
samples were fragmented, end-repaired and polyadenylated before ligation of TruSeq adapters containing the 
index for multiplexing. Fragments containing TruSeq adapters on both ends were selectively enriched by PCR. 
The quality and quantity of the enriched libraries were validated using a Qubit (1.0) Fluorometer and the Caliper 
GX LabChip GX (Caliper Life Sciences, Inc.) and qPCR. The libraries were normalised to 10 nM in Tris-Cl, pH 
8.5 with 0.1% Tween-20 based on the qPCR values.
The TruSeq PE Cluster Kit v3-cBot-HS or TruSeq SR Cluster Kit v3-cBot-HS (Illumina, Inc.) was used for 
cluster generation using 10 pM of pooled normalised libraries on the cBOT. Sequencing were performed on the 
Illumina HiSeq 2500 paired end using the TruSeq SBS Kit v3-HS (Illumina, Inc.). Tachyzoites were sequenced 
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on quarter lanes at 2 × 100 bp; EES were sequenced on 0.5 or 1 lanes each at 2 × 100 bp or 2 × 125 bp. Where few 
reads were obtained, the samples were sequenced twice.
Read data were quality controlled with Fastqc and FastqScreen to confirm reads were of high quality and free 
of contaminants. Read-alignment was done using the STAR-aligner48. As reference, we used the genome of T. 
gondii strain ME49 (ToxoDB Release 24). We computed gene expression values (normalised counts) with the 
function featureCounts from the R package Rsubread49. Developmental progress was assessed by hierarchical 
clustering of the samples and re-assigned to groups EES1–5 (see results, Figure S1). Differential expression was 
computed using the generalised linear model implemented in the Bioconductor package DESeq 250 yielding the 
log2 value of the fold changes, p-values and false discovery rates (FDR). We considered a fold change of >4 for 
differential expression and used a p-value cut-off of 0.05 to determine significance. Genes with more than 10 
normalised counts were considered expressed (is present = TRUE). We also calculated an additional value for 
transcript abundance normalised to transcript length: FPKM (fragments per kilobase of exon model per million 
mapped reads). The raw data and FPKMs have been deposited in NCBI’s Gene Expression Omnibus51 (Accession 
number GSE108740). Further annotation was performed by gene ontology mapping using Blast2Go52 v4.1.9 
using an upper cut-off e-value of <0.0005.
Construction of HAP2 knockout and sequencing. We employed a CRISPR/Cas9 strategy to insert a 
frameshift within the first 20 nt of the first exon of hap2 in the CZ clone H3 T. gondii, with consequential dis-
ruption of the final translated HAP2 protein. First, the tubulin A1 promoter from the CZ clone H3 genome 
was amplified and inserted into KpnI, NsiI, digested plasmid to exchange the SAG1 promoter in the vec-
tor described previously53. Inverse PCR was used to exchange the sgRNA of UPRT with the sgRNA for HAP2 
with Ph-sgRNA_TgHAP2mutF (5′-TGGATCCACCACTGCCGCGAGTTTTAGAGCTAGAAATAGC-3′) and 
Ph-genCas9mutR (5′-AACTTGACATCCCCATTTAC-3′) to yield plasmid pTub1::CAS9-U6::sgHAP2 (Fig. 4b). 
Transfection of CZ clone H3 was carried out as described53. Twenty-four hours post-transfection, transiently 
transfected GFP + parasites were purified by flow cytometry as described previously54 (Figure S4) and the 
HAP2 KO clone E6 clone was further purified using two rounds of limiting dilution cloning. Sanger sequenc-
ing of PCR products using HAP2ko-dia-F (5′-GAAACAGCACTACAGCTCTTCGC-3′) and HAP2ko-dia-R 
(5′ ATGCATGAACAAGGTATGGTTCTGC-3′) was used to confirm the knockout. Sanger sequencing of 
PCR products using HAP2ko-dia-F (5′-GAAACAGCACTACAGCTCTTCGC-3′) and HAP2ko-dia-R (5′ 
ATGCATGAACAAGGTATGGTTCTGC-3′) was used to confirm disruption of the hap2 ORF.
For whole genome sequencing, genomic DNA from in vitro cultured parasites from HAP2 KO and CZ clone 
H3 was extracted with the QIAamp DNA Mini Kit (QIAGEN) using the manufacturer’s protocol. DNA was 
sheared using Covaris Adaptive Focused AcousticsTM (AFA) technology using settings specific to the fragment 
size of 550 bp. The fragmented DNA was size selected using AMpure beads (Beckman-Coulter), end-repaired and 
polyadenylated. Using the TruSeq HT DNA NanoSample Prep Kit v2 (Illumina Inc.), TruSeq adapters containing 
the index for multiplexing were ligated to the fragmented DNA which was then selectively enriched by PCR. The 
quality and quantity of the enriched libraries were validated using Qubit® (1.0) Fluorometer and the Tapestation 
(Agilent). The libraries were normalised to 10 nM in Tris-Cl 10 mM, pH 8.5 with 0.1% Tween-20. The Hiseq. 
4000 PE Cluster Kit (Illumina) was used for cluster generation using 8 pM of pooled normalised libraries on the 
cBOT V2. Paired end sequencing with 2 × 150 bp was performed on the Illumina HiSeq. 4000 using the HiSeq. 
3000/4000 SBS Kit (Illumina).
Using Trimmomatic55, raw reads were trimmed of the sequencing adapters and further trimmed 50 bases 
from the 3′ end to remove low-quality ends. A minimum average Phred quality of 25 and a minimum length of 
25 bases were adopted. The sequences passing these filters were aligned to the genome of T. gondii ME49 (Release 
33) using Bowtie256 with default settings. Putative variants were then identified by following GATK best practices 
for DNA-sequencing57,58 and variants with an alternative allele frequency below 10% in the CZ clone H3 and 
above 90% in the HAP2 KO were marked as HAP2 KO-specific variants.
sporulation assay. Sporulation of oocysts of T. gondii was assessed by seeding small Erlenmeyer flasks, con-
taining 5 ml of 2% sulphuric acid, with oocysts of the CZ clone H3 or the HAP2 KO parasites. The flasks were left 
at room temperature and stirred twice per day. For the CZ clone H3 oocysts, four flasks were set up and around 
100 oocysts were assessed for sporulation under a light microscope from each flask on day 2, 4 and 8 after seeding. 
In the case of the HAP2 KO oocysts, it was not possible to set up a series of Erlenmeyer flasks because of the low 
number of oocysts recovered; hence, in this case, sporulation was undertaken in a Petri dish and 1000 oocysts 
were assessed for sporulation.
Quantitative real-time pCR. To extract genomic DNA, oocysts were suspended in ice cold water and neat 
Triton X-100 was added to the suspension until foam appeared. The detergent was washed away and the oocysts 
were treated with 14% bleach on ice for 10 min. The bleach was then diluted with H2O, and oocysts were washed 
with ice cold H2O before DNA extraction or freeze drying. Genomic DNA was extracted from either freshly treated 
or freeze-dried oocysts using the Faecal DNA Miniprep kit from Zymo following the manufacturer’s protocol. 
Real-time PCR was performed using the QuantiFast SYBR Green PCR Kit (QIAGEN) on the QuantStudio 7 Flex 
Real-Time PCR System (Applied Biosystems) and the primers Act1-F (5′-GGCGAACCGTGAGAGAATGA-3′) 
with Act1-R (5′-ACAGAGAAAGAACGGCCTGG-3′) or clp-F (5′-ATTATGCGGTCCAAGCGGAA-3′) with 
clp-R (5′-CTACATATCCTGGAGGCGCTC-3′), resulting in amplicons of 89 bp and 158 bp, respectively. The 
cycling conditions used included denaturation at 95 °C for 5 min followed by 40 cycles of 10 s at 95 °C and 30 s 
at 60 °C. Melt curve determination was performed for 15 s at 95 °C, 1 min at 60 °C and 15 s at 95 °C. All reactions 
were done in triplicate. Data were analysed using the comparative Ct method31.
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Inoculation and challenge trial design. Fourteen 9-week old European specific pathogen free (SPF) cats 
were purchased from Isoquinem S.L. (Barcelona, Spain) and allowed 3 weeks to acclimatise to their new sur-
roundings at the University of Zurich before the challenge trial. The cats were tested by ELISA (see below) for 
the presence of antibodies to T. gondii and for oocysts in their faeces prior to the start of the inoculation and 
challenge trial; all cats were seronegative and all faeces examined were oocyst-free. Each cat was vaccinated twice 
with Feligen CRP ad us. vet. (Virbac AG, Switzerland) prior to commencement of the challenge trial. The cats 
were free to move about, in three groups of four, five and five cats, in three rooms of approximately 10 m2, 11 m2 
and 11 m2, respectively. Figure 5a outlines the design of the inoculation and challenge trial: one group of five cats 
was inoculated at 12 and 17 weeks of age with tissue cysts of T. gondii CZ clone H3 and challenged at 22 weeks 
of age with tissue cysts of T. gondii CZ clone H3; the group of four cats was inoculated at 12 and 17 weeks of age 
with tissue cysts of T. gondii HAP2 KO and challenged at 22 weeks of age with tissue cysts of T. gondii CZ clone 
H3; and the final group of five cats was left uninoculated (i.e., naïve) until challenged at 22 weeks of age with tissue 
cysts of T. gondii CZ clone H3. Blood samples were taken from each cat immediately prior to inoculation and 
challenge at 12, 17 and 22 weeks of age as well as when the cats were 26 and 30 weeks old; these samples were ana-
lysed for antibodies by ELISA (see below). Faeces were collected at 2 day intervals after inoculation and challenge 
and oocysts counted (see below).
preparation of infectious inocula. Eight to ten-week old CBA/Rj mice (Janvier, France) and Fischer 
344/IcoCrl rats (Charles River, Italy) were infected by intraperitoneal injection of 200 μl PBS containing 1,000 
tachyzoites of either T. gondii CZ clone H3 (mice and rats) or the HAP2 KO isolate (mice only). The use of 
CBA/Rj mice and Fischer 344/IcoCrl rats as hosts for T. gondii has been described previously59,60. At 48 or 49 
days post-injection, blood samples from five randomly-chosen mice and rats were taken and tested for antibody 
production by ELISA (see below); all were antibody-positive. At 50 days post-injection, rodents were killed and 
brains, eyes, hearts and muscles collected and diced finely until homogenised. The presence of T. gondii in the 
inocula was confirmed by PCR, as described previously61. For the first inoculation of cats, brains, eyes and hearts 
plus 320 g of skeletal muscle from 32 T. gondii CZ clone H3 strain infected mice and brains, eyes and hearts plus 
200 g of skeletal muscle from 20 T. gondii CZ HAP2 KO strain infected mice were used. For the second inocula-
tion of cats, brains, eyes and hearts plus 300 g of skeletal muscle from 30 mice infected with T. gondii CZ strain, 
and brains and hearts plus 300 g muscles of 30 T. gondii CZ HAP2 KO strain infected mice were used. For the 
challenge infections of cats, brains, eyes and hearts plus 560 g skeletal muscle from 39 rats infected with T. gondii 
CZ strain were used. For each inoculation, the preparations were homogenised and divided into equal portions, 
which were fed to cats individually. It should be noted that, on two out of three occasions, a significant percentage 
(13% and 91%) of CBA/Rj mice infected with the CZ clone H3, and on one of two occasions, a significant per-
centage (48%) of CBA/Rj mice infected with the HAP2 KO strain of T. gondii either died unexpectedly overnight 
or had to be euthanised under our animal care and ethics protocols due to the exhibition of symptoms of acute 
toxoplasmosis (including ruffled fur, hunched posture and > 20% weight loss), even after administration of sul-
fadiazine62 and despite the fact that brain cysts could not be observed by light microscopy in infected mice. In 
contrast, large brain cysts were detected readily in infected Fischer 344/IcoCrl rats and only a single rat, of sixty 
infected with T. gondii CZ clone H3, developed mild ocular symptoms. Thus, we used tissue cysts from rats for the 
final challenge inocula in our trial and now prefer this host for the production of tissue cysts of T. gondii.
Specific antibody measurement. ELISA plates (NUNC Maxisorp, Thermo Scientific, Roskilde DK) were 
coated with 100 µl per well using 10 µl of T. gondii tachyzoite antigen in 1 ml coating buffer (0.1 M carbonate/
bicarbonate, pH 9.6) overnight at 4 °C. Production of this antigen was as described previously63. The plates were 
washed and subsequently blocked with 300 μl buffer II (PBS (pH 7.2) with 0.02% (w/v) NaN3, 0.05% (w/v) bovine 
haemoglobin (Fluka/Sigma Aldrich, Switzerland) and 0.3% (w/v) Tween-20) per well for 30 min. All further 
incubation steps took place in a 37 °C humid chamber for 1 h, followed by four washes with ELISA wash buffer 
(physiological saline containing 0.3% Tween-20). Sera were then used in a 1:200 dilution in buffer II. Alkaline 
phosphatase labeled goat anti-feline IgG H + L (Southern Biotech, USA) diluted 1:4000, goat anti-mouse IgG 
A3562 (Sigma-Aldrich, Switzerland) diluted 1:10,000 and goat anti-rat igG A8438 (Sigma-Aldrich, Switzerland) 
diluted 1:4000 in buffer II were used as conjugate. Antibody reactions were visualised by adding 100 µl of sub-
strate (1 mg/ml of 4-nitrophenylphosphate (Sigma-Aldrich, Switzerland) in 0.05 M carbonate/bicarbonate buffer 
(pH 9.8) containing 1 mM MgCl2) and the absorbance was read at 405 nm in an ELISA reader (Multiscan RC, 
BioConcept, Allschwil, Switzerland) after 10 min of incubation at 37 °C.
oocyst counting. Since we could not house cats in individual cages under our animal experimentation pro-
tocols, we had to devise novel solutions to allow us to determine individual oocyst excretion rates in our infected 
cats. Hence, individual cats infected with T. gondii were fed different coloured plastic beads in every meal. These 
coloured beads proved readily detectable and allowed us to separate faeces from each cat. Faeces were collected 
from 2 days post-inoculation until no oocysts were observed for at least 4 days. Faeces from individual cats were 
pooled every 2 days, i.e., day 1 + 2 post-inoculation, day 3 + 4 post-inoculation, day 5 + 6 post-inoculation, etc. 
Faeces were soaked in 0.1% Tween-80 (Sigma-Aldrich) overnight at room temperature.
We adapted elements of three published protocols for enumerating oocysts in cat faeces32,64,65. In brief, fae-
cal samples were first homogenised using a wooden palette stick and one-tenth of each was passed through a 
metal strainer, washed with tap water and re-suspended to a final volume of 200 ml. A 50 ml sub-sample of this 
suspension was centrifuged at 1000 x g for 10 min at room temperature (Allegra X-15R centrifuge, Beckman 
Coulter). The supernatants of each sample were discarded and the pellets re-suspended in sucrose solution (spe-
cific density = 1.2) to a final volume of 50 ml, followed by centrifugation at 1600 x g for 10 min at room tem-
perature, without brakes, to guarantee optimal floatation. The top 10 ml of each supernatant was collected and 
www.nature.com/scientificreports/
1 2Scientific RepoRts |          (2019) 9:1474  | https://doi.org/10.1038/s41598-018-37671-8
mixed, and 1 ml was transferred into a mini-FLOTAC chamber. The mini-FLOTAC device was left undisturbed 
for 10 min to allow oocysts to float to the top of the counting chamber. Two different quarters were counted under 
a light microscope and the mean value of these two counts was multiplied by 1,600 to obtain the total number of 
oocysts in the original faecal sample. In cases where oocyst numbers were particularly high, the final subsample in 
sucrose was diluted 1:10 or 1:100 with additional sucrose solution for counting. Every sample was counted twice, 
by two different assessors to ensure precision. Additionally, internal protocol tests were conducted regularly, by 
repeated counts of samples seeded with four different known concentrations of oocysts. In cases where oocysts 
could not be seen in the mini-FLOTAC chambers, a 10 μl sample was drawn from the very top of the final 10 ml 
flotation sample, after this sample had rested undisturbed for at least 10 mins to ensure floatation of all oocysts; 
this sample was placed on a glass microscope slide, with coverslip, and screened under a light microscope for the 
presence of oocysts. This adapted protocol for oocyst enumeration proved to be efficient and reliable, with appro-
priate sensitivity of detection for vaccination trials.
tissue cyst purification and genotyping. Freshly harvested cat brains were washed several times 
in ice cold PBS. Approximately, 1/6th of the volume was cut into small pieces and suspended in 12–15 ml 
ice cold PBS and syringe homogenised using 16 G, 18 G, 20 G and 22 G needles. Ice cold PBS (to a total vol-
ume of 18–23 ml) and 0.33% Tween-80 were then added to the homogenate. Each sample was divided into 
two and tissue cysts were fractionated on a 90%/30% Percoll gradient as described previously40. The inter-
face containing the tissue cysts was harvested and washed twice with ice cold PBS at 2000 rpm for 10 min 
at 4 °C. The washed fraction was syringe homogenised using 18 G, 22 G, 24 G and 26 G needles and used 
to infect HFFs; the resulting tachyzoites were propagated in vitro. Genomic DNA was extracted from 
tachyzoites using the QIAamp DNA mini kit (QIAGEN) as per the manufacturer’s protocol. PCRs were then 
performed using HAP2ko-dia-F (5′-GAAACAGCACTACAGCTCTTCGC-3′) and HAP2ko-dia-R (5′- 
ATGCATGAACAAGGTATGGTTCTGC-3′). Control PCRs were performed with HAP2 KO and CZ clone H3 
genomic DNA from tachyzoites. Diagnostic digestions of the PCR products were performed with XcmI (NEB 
Biolabs) and PCR products were analysed for nucleotide sequence by Sanger sequencing (Microsynth, Balgach, 
Switzerland). Image acquisition was performed with an imager from the Alpha Innotech Corporation using the 
AlphaEase FC software (version 6.0.0).
ethics statement. Animal experiments were performed under the direct supervision of a veterinary spe-
cialist, and according to Swiss law and guidelines on Animal Welfare and the specific regulations of the Canton 
of Zurich under permit numbers 130/2012 and 019/2016, as approved by the Veterinary Office and the Ethics 
Committee of the Canton of Zurich (Kantonales Veterinäramt Zürich, Zollstrasse 20, 8090 Zürich, Switzerland).
Data Availability
This study is based on RNA-Seq data that are publicly available and have been deposited in NCBI’s Gene Ex-
pression Omnibus with the accession number GSE108740 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?ac-
c=GSE108740). Whole Genome Sequencing (WGS) raw data can be accessed in NCBI’s Sequence Read Archive 
(SRA) using accession number: SRP142285.
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